Skip to main content
ACS Omega logoLink to ACS Omega
. 2025 Oct 9;10(41):49019–49034. doi: 10.1021/acsomega.5c07577

Mathematical Modeling of H1-Antihistamines: A QSPR Approach Using Topological Indices

Merin Manuel 1, Parthiban Angamuthu 1,*
PMCID: PMC12547784  PMID: 41141767

Abstract

Allergic diseases represent a significant global health burden, requiring effective and safe therapeutic agents for long-term management. H1-antihistamines are among the most widely prescribed and over-the-counter drugs for treating allergic conditions, yet their variable physicochemical and pharmacokinetic properties present challenges in optimizing drug selection, safety, and efficacy. A systematic exploration of their structure–property relationships is, therefore, essential for guiding rational drug design. In this study, the Quantitative Structure–Property Relationship (QSPR) of a selection of H1-antihistamines, including both conventional and second-generation compounds, is investigated by using degree-based topological indices and linear regression models. The computed indices are systematically correlated to key physicochemical properties, revealing strong and statistically significant relationships. These findings provide deeper insights into the molecular factors influencing drug behavior and highlight the predictive utility of topological descriptors. Overall, the developed QSPR models not only enhance the understanding of H1-antihistamines but also establish a framework that can accelerate the identification and optimization of next-generation agents with improved pharmacological profiles.


graphic file with name ao5c07577_0012.jpg


graphic file with name ao5c07577_0010.jpg

1. Introduction

Histamine, an endogenous amine found throughout animal tissues, is involved in various physiological processes, most notably in immune responses and allergic reactions. Its effects are mediated through histamine receptors, of which H1 and H2 are the most pharmacologically significant. The therapeutic management of histamine-mediated conditions is primarily achieved using antihistamines, which are the agents that block the action of histamines at these receptor sites.

Antihistamines targeting H1-receptors are commonly used in the treatment of allergic conditions, such as rhinitis, urticaria, and anaphylaxis. These agents are broadly classified into first- and second-generation compounds based on their ability to cross the blood–brain barrier and their associated side effect profiles. First-generation H1-antihistamines tend to interact with both central and peripheral receptors, often leading to sedative effects. In contrast, second-generation compounds are more selective for peripheral receptors and are associated with a lower incidence of central nervous system adverse effects. , Refer to Table for the classification of drugs used in this study.

1. List of H1-Antihistamines Used in the Study.

classification name
first generation/highly sedative diphenhydramine
  promethazine
  hydroxyzine
first generation/moderately sedative pheniramine
  cyproheptadine
  meclizine
  cinnarizine
first generation/mild sedative chlorpheniramine
  triprolidine
  clemastine
second generation fexofenadine
  loratadine
  desloaratadine
  cetirizine
  azelastine
  ebastine
  rupatadine

Although both first- and second-generation antihistamines are widely available, often as over-the-counter medications, their diverse physicochemical and pharmacokinetic properties continue to pose challenges in terms of drug selection, safety, and therapeutic efficacy. The extensive clinical use of these agents, coupled with the demand for improved therapeutic profiles, highlights the necessity of rational drug design to develop newer and more selective compounds. Moreover, recent studies have suggested additional clinical benefits beyond allergy treatment. For instance, desloratadine and loratadine have been associated with substantially improved survival outcomes in breast cancer and melanoma patients, with desloratadine showing benefits across immunogenic tumors and loratadine improving survival in selected tumor types. In addition, H1-antihistamines find broad applications in dermatology, further underscoring their therapeutic relevance.

In recent years, computational approaches have become integral to pharmaceutical research, particularly in the early stages of drug development. Among these, quantitative structure–property relationship (QSPR) modeling has proven to be a powerful tool for predicting the physicochemical and biological properties of compounds based on their molecular structure. QSPR methods enhance the efficiency of drug discovery by providing a cost-effective means of screening and optimizing candidate molecules.

Central to QSPR modeling is the use of molecular descriptors, with topological indices (TIs) playing a particularly significant role. These indices are derived from graph-theoretical representations of molecules, where atoms are treated as vertices and chemical bonds are treated as edges. Degree-based topological indices (DTIs) capture essential aspects of molecular connectivity and branching, offering valuable insights into the structural attributes that influence the chemical behavior and biological activity. Beyond the conventional degree-based indices, TIs derived from other graph parameters have gained significant attention in recent years. Among these, neighborhood degree-based topological indices (NDTIs) are particularly noteworthy. Unlike traditional indices that account for only the immediate degree of a vertex, NDTIs incorporate information from the extended neighborhood, thereby capturing an additional layer of structural branching. This makes the comparison between the conventional and modified forms of TIs both relevant and valuable.

QSPR analyses employing DTIs have been widely applied to various therapeutic classes of drugs, including those used in the treatment of cancer, hepatitis, malaria, breast cancer, pyelonephritis, Lyme disease, glaucoma, postpartum depression, and as antibiotics. In addition, NDTIs have been effectively employed in the analysis of various drug properties, including those of asthma medications, antituberculosis drugs, heart transplant drugs, and anesthetic agents. There remains a significant gap in the literature concerning the analysis of diverse properties of H1-antihistamines in relation to their chemical structures. The present study addresses this gap by providing valuable insights into the structural determinants of drug behavior and by demonstrating the predictive potential of topological descriptors.

The present study applies 12 DTIs and ten NDTIs to a selection of H1-antihistamines in order to model and predict key physicochemical properties. The chemical structures of the set of H1-antihistamines analyzed in this study are listed in Figure . These structures were retrieved from the PubChem database. Regression analysis is employed to establish relationships between the indices and these properties, enabling the development of predictive models. These models are further used to evaluate additional antihistamines, including cyclizine and doxylamine, with the aim of assessing their characteristics within the same analytical framework. This methodological approach contributes to a deeper understanding of the structural basis for drug behavior and supports the broader goal of designing next-generation antihistamines with enhanced efficacy and safety profiles.

1.

1

Chemical structures of H1-antihistaminics.

2. Computation of Topological Indices

In this study, all graphs G = (V, E) are assumed to be connected, where the vertex set V(G) and edge set E(G) represent the atoms and chemical bonds of a molecule, respectively. Each vertex vV(G) has a degree d v , indicating the number of vertices adjacent to it, an idea analogous to the chemical concept of valence, which describes the bonding capacity of an atom. The notation N(v) denotes the set of vertices adjacent to v in G.

The chemical graphs analyzed here were constructed from the molecular structures of selected H1-antihistamines. For simplicity, distinctions between single and double bonds are not considered, and hydrogen atoms are omitted from the graph structure, following standard practice in chemical graph theory.

2.1. Degree-Based Topological Indices

The topological indices defined in Table are based on the degrees of the vertices in the given graph. These indices are calculated using the edge partition technique, which categorizes edges according to the degrees of their end points. The quantities Edu,dv denote the number of edges connecting vertices of degrees d u and d v , with their corresponding values presented in Table .

2. List of DTIs Used in the Study.

atom-bond connectivity index
ABC(G)=z1z2E(G)dz1+dz22dz1×dz2
atom-bond sum-connectivity index
ABS(G)=z1z2E(G)dz1+dz22dz1+dz2
forgotten index
F(G)=z1z2E(G)[dz12+dz22]
geometric–arithmetic index
GA(G)=z1z2E(G)2dz1×dz2dz1+dz2
harmonic index
H(G)=z1z2E(G)2dz1+dz2
inverse sum index
IS(G)=z1z2E(G)dz1×dz2dz1+dz2
Randić index
R(G)=z1z2E(G)1dz1×dz2
sum-connectivity index
SCI(G)=z1z2E(G)1dz1+dz2
symmetric division index
SD(G)=z1z2E(G)dz1dz2+dz2dz1
first Zagreb index
M1(G)=z1z2E(G)[dz1+dz2]
hyper-Zagreb index
HM(G)=z1z2E(G)[dz1+dz2]2
second Zagreb index
M2(G)=z1z2E(G)[dz1×dz2]

3. Edge Partition of the Candidate Drugs in Terms of Vertex Degrees.

sl. no. name E 1,2 E 1,3 E 1,4 E 2,2 E 2,3 E 2,4 E 3,3 E 3,4
1 diphenhydramine 0 2 0 10 6 0 2 0
2 promethazine 0 3 0 6 8 0 5 0
3 hydroxyzine 1 1 0 12 11 0 3 0
4 pheniramine 0 2 0 9 6 0 2 0
5 cyproheptadine 0 1 0 9 10 0 5 0
6 meclizine 0 2 0 10 16 0 3 0
7 cinnarizine 0 0 0 16 12 0 3 0
8 chlorpheniramine 0 3 0 7 8 0 2 0
9 triprolidine 0 1 0 10 10 0 2 0
10 clemastine 0 2 1 10 9 1 1 2
11 fexofenadine 0 3 3 14 14 0 1 5
12 loratadine 1 2 0 8 13 0 6 0
13 desloaratadine 0 1 0 9 10 0 5 0
14 cetirizine 0 3 0 11 12 0 3 0
15 azelastine 0 3 0 8 14 0 5 0
16 ebastine 0 1 3 14 16 0 3 1
17 rupatadine 0 2 0 9 18 0 5 0

As an example, Theorem 1 presents the detailed computation of the DTIs for diphenhydramine.

Theorem 1. For the chemical graph C of diphenhydramine, M 1(C) = 90, M 2(C) = 100, H(C) = 9.0667, HM(C) = 414, ABC(C) = 14.28, R(C) = 9.2709, GA(C) = 19.6108, SCI(C) = 9.4998, IS(C) = 21.7, SD(C) = 43.6667, F(C) = 214, and ABS(C) = 14.7659.

Proof. Using the definitions provided in Table and the edge partitions detailed in Table

M1(C)=E1,3(1+3)+E2,2(2+2)+E2,3(2+3)+E3,3(3+3)=90 1a
M2(C)=E1,3(1×3)+E2,2(2×2)+E2,3(2×3)+E3,3(3×3)=100 1b
H(C)=E1,3(21+3)+E2,2(22+2)+E2,3(22+3)+E3,3(23+3)=9.0667 1c
HM(C)=E1,3(1+3)2+E2,2(2+2)2+E2,3(2+3)2+E3,3(3+3)2=414 1d
ABC(C)=E1,31+321×3+E2,22+222×2+E2,32+322×3+E3,33+323×3=14.28 1e
R(C)=E1,31×3+E2,22×2+E2,32×3+E3,33×3=9.2709 1f
GA(C)=2E1,3(1×31+3)+2E2,2(2×22+2)+2E2,3(2×32+3)+2E3,3(3×33+3)=19.6108 1g
SCI(C)=E1,31+3+E2,22+2+E2,32+3+E3,33+3=9.4998 1h
IS(C)=E1,3(1×31+3)+E2,2(2×22+2)+E2,3(2×32+3)+E3,3(3×33+3)=21.7 1i
SD(C)=E1,3(13+31)+E2,2(22+22)+E2,3(23+32)+E3,3(33+33)=43.6667 1j
F(C)=E1,3(12+32)+E2,2(22+22)+E2,3(22+32)+E3,3(32+32)=214 1k
ABS(C)=E1,31+321+3+E2,22+222+2+E2,32+322+3+E3,33+323+3=14.7659 1l

The remaining indices can be computed similarly as in eqs –, by applying the edge partition method to their respective definitions. A consolidated summary of the computed values for all topological indices is presented in Table .

4. Computed DTI Values for the Candidate H1-Antihistamines.

name M 1 M 2 H HM ABC R GA SCI IS SD F ABS
diphenhydramine 90 100 9.0667 414 14.2800 9.2709 19.6108 9.4998 21.7000 43.6667 214 14.7659
promethazine 106 126 9.3667 524 15.6823 9.6647 21.4364 10.1190 25.3500 49.3333 272 16.6432
hydroxyzine 128 146 12.5667 600 19.7871 12.7752 27.5866 13.2214 31.1167 59.6667 308 20.7398
pheniramine 86 96 8.5667 398 13.5729 8.7709 18.6108 8.9998 20.7000 41.6667 206 14.0587
cyproheptadine 120 144 10.6667 590 17.5849 10.8265 24.6640 11.5134 29.2500 53.0000 302 18.8995
meclizine 146 169 13.4000 700 22.0178 13.6867 30.4088 14.3802 35.2000 67.3333 362 23.3283
cinnarizine 142 163 13.8000 664 21.7990 13.8990 30.7576 14.5913 34.9000 64.0000 338 23.0584
chlorpheniramine 92 103 8.8667 432 14.3894 9.1647 19.4364 9.3942 21.8500 45.3333 226 14.9008
triprolidine 106 121 10.1667 498 16.2920 10.3265 22.6640 10.7886 25.7500 49.0000 256 17.1571
clemastine 124 145 11.2381 612 18.5988 11.5932 25.2725 12.0446 29.3619 59.0833 322 19.5545
fexofenadine 194 230 17.0619 978 28.7407 17.7242 38.6639 18.4007 45.5214 93.5000 518 30.2312
loratadine 144 172 12.8667 710 21.1893 13.1690 29.4122 13.8406 34.7667 65.3333 366 22.6172
desloratadine 120 144 10.6667 590 17.5849 10.8265 24.6640 11.5134 29.2500 53.0000 302 18.8995
cetirizine 134 152 12.8000 632 20.7129 13.1310 28.3556 13.5913 32.1500 64.0000 328 21.6441
azelastine 144 170 12.7667 706 21.3392 13.1142 29.3152 13.8022 34.5500 66.3333 366 22.7050
ebastine 180 206 16.3857 872 27.2733 16.8980 36.9325 17.5998 42.5643 86.8333 460 28.6186
rupatadine 164 195 14.3667 806 24.0582 14.6698 33.3684 15.5911 39.6000 73.6667 416 25.8034

2.2. Neighborhood Degree-Based Topological Indices

The indices defined in Table are derived from the neighborhood degree D z of a vertex z, which is defined as the sum of the degrees of all vertices adjacent to z, i.e., Dz=z1N(z)dz1 .

5. List of NDTIs Used in the Study.

additive NDTIs
neighborhood first Zagreb index
NM1(G)=z1V(G)[Dz1]2
neighborhood forgotten index
NF(G)=z1V(G)[Dz1]3
neighborhood second Zagreb index
NM2(G)=z1z2E(G)[Dz1×Dz2]
neighborhood harmonic index
NH(G)=z1z2E(G)2Dz1+Dz2
neighborhood inverse-sum index
NI(G)=z1z2E(G)Dz1×Dz2Dz1+Dz2
multiplicative NDTIs
fifth multiplicative first Zagreb index
ΠNM1(G)=z1z2E(G)[Dz1+Dz2]
fifth multiplicative second Zagreb index
ΠNM2(G)=z1z2E(G)[Dz1×Dz2]
multiplicative total neighborhood index
ΠTN(G)=z1V(G)Dz1
multiplicative first neighborhood index
ΠNM(G)=z1V(G)[Dz1]2
multiplicative F 1 neighborhood index
ΠNF(G)=z1V(G)[Dz1]3

The vertex and edge partitions based on neighborhood degree sums, which are used in the computation of NDTIs, are presented in Tables and , respectively.

6. Vertex Partition of the Candidate Drugs Based on Neighborhood Degree Sum.

  D u
  2 3 4 5 6 7 8 9 10
diphenhydramine 0 2 8 6 0 2 1 0 0
promethazine 0 3 4 5 3 2 3 0 0
hydroxyzine 1 2 6 12 1 3 0 1 0
pheniramine 0 2 7 6 0 2 1 0 0
cyproheptadine 0 1 4 11 0 3 2 1 0
meclizine 0 2 4 14 4 3 0 1 0
cinnarizine 0 0 10 12 2 3 0 1 0
chlorpheniramine 0 3 4 9 0 2 1 0 0
triprolidine 0 1 5 11 1 2 1 0 0
clemastine 0 2 6 10 2 1 2 1 0
fexofenadine 0 3 10 14 3 1 5 0 1
loratadine 1 3 2 12 2 4 2 1 0
desloaratadine 0 1 5 9 1 3 2 1 0
cetirizine 0 3 6 13 1 3 0 1 0
azelastine 0 3 3 12 3 3 3 0 0
ebastine 0 1 10 14 5 3 2 0 0
rupatadine 0 2 3 14 5 3 2 1 0

7. Edge Partition of the Candidate Drugs Based on Neighborhood Degree Sum.

Diphenhydramine
D u , D v 3, 4 4, 4 4, 5 5, 7 5, 8 7, 8              
no. of edges 2 4 7 4 1 2              
Promethazine
D u , D v 3, 5 3, 6 4, 4 4, 5 5, 6 5, 7 5, 8 6, 6 6, 7 6, 8 7, 8 8, 8  
no. of edges 2 1 2 4 1 2 2 1 2 1 2 2  
Hydroxyzine
D u , D v 2, 3 3, 4 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 5, 9 7, 9      
no. of edges 1 1 1 4 3 6 3 5 1 3      
Pheniramine
D u , D v 3, 4 4, 4 4, 5 5, 5 5, 7 5, 8 7, 8            
no. of edges 2 4 5 1 4 1 2            
Cyproheptadine
D u , D v 3, 5 4, 4 4, 5 5, 5 5, 7 5, 8 7, 8 7, 9 8, 9        
no. of edges 1 2 4 5 6 2 2 1 2        
Meclizine
D u , D v 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 6, 6 7, 9          
no. of edges 2 2 4 7 5 6 2 3          
Cinnarizine
D u , D v 4, 4 4, 5 5, 5 5, 6 5, 7 7, 9              
no. of edges 6 8 2 6 6 3              
Chlorpheniramine
D u , D v 3, 4 3, 5 4, 4 4, 5 5, 5 5, 7 5, 8 7, 8          
no. of edges 2 1 2 3 5 4 1 2          
Triprolidine
D u , D v 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 5, 8 7, 8          
no. of edges 1 3 4 5 3 4 1 2          
Clemastine
D u , D v 3, 5 3, 6 4, 4 4, 5 4, 6 4, 9 5, 5 5, 6 5, 7 5, 8 6, 7 6, 9 8, 9
no. of edges 1 1 2 5 1 1 4 1 2 4 1 1 2
Fexofenadine
D u , D v 3, 6 4, 4 4, 5 4, 6 4, 8 4, 10 5, 5 5, 6 5, 7 5, 8 6, 7 8, 8 8, 10
no. of edges 3 4 6 1 2 1 4 4 2 8 1 1 3
Loratadine
D u , D v 2, 3 3, 5 3, 6 4, 4 4, 5 5, 5 5, 6 5, 7 5, 8 6, 7 7, 8 7, 9 8, 9
no. of edges 1 2 1 1 2 5 2 7 2 2 2 1 2
Desloaratadine
D u , D v 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 5, 8 6, 7 7, 8 7, 9 8, 9    
no. of edges 1 3 4 3 1 5 2 1 2 1 2    
Cetirizine
D u , D v 3, 4 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 7, 9          
no. of edges 2 1 3 5 6 3 6 3          
Azelastine
D u , D v 3, 5 3, 7 4, 4 4, 5 5, 5 5, 6 5, 7 5, 8 6, 6 6, 7 6, 8 7, 8 8, 8
no. of edges 2 1 1 4 7 2 2 2 1 2 1 4 1
Ebastine
D u , D v 3, 6 4, 4 4, 5 4, 6 5, 5 5, 6 5, 7 5, 8 6, 6 6, 7 6, 8 7, 8  
no. of edges 1 4 6 3 4 6 6 2 1 1 2 2  
Rupatadine
D u , D v 3, 5 4, 4 4, 5 5, 5 5, 6 5, 7 5, 8 6, 6 6, 7 7, 8 7, 9 8, 9  
no. of edges 2 1 4 6 5 5 2 3 1 2 1 2  

For illustration, Theorem 2 provides a detailed computation of the NDTIs for diphenhydramine.

Theorem 2. For the chemical graph C of diphenhydramine, NM 1(C) = 458, NM 2(C) = 520, NF(C) = 2514, NI(C) = 49.194, NH(C) = 4.214, ΠNM 1(C) = 5.82 × 1019, ΠNM 2(C) = 2.27 × 1027, ΠTN(C) = 3.61 × 1012, ΠNM(C) = 1.31 × 1025, and ΠNF(C) = 4.72 × 1037.

Proof. Using the definitions from Table and the vertex and edge partitions from Tables and

NM1(C)=2×32+8×42+6×52+2×72+1×82=458 2a
NM2(C)=2[3×4]+4[4×4]+7[4×5]+4[5×7]+1[5×8]+2[7×8]=520 2b
NF(C)=2×33+8×43+6×53+2×73+1×83=2514 2c
NI(C)=2(3×43+4)+4(4×44+4)+7(4×54+5)+4(5×75+7)+1(5×85+8)+2(7×87+8)=49.194 2d
NH(C)=2(23+4)+4(24+4)+7(24+5)+4(25+7)+1(25+8)+2(27+8)=4.214 2e
ΠNM1(C)=[3+4]2×[4+4]4×[4+5]7×[5+7]4×[5+8]1×[7+8]2=5.82×1019 2f
ΠNM2(C)=[3×4]2×[4×4]4×[4×5]7×[5×7]4×[5×8]1×[7×8]2=2.27×1027 2g
ΠTN(C)=32×48×56×72×81=3.61×1012 2h
ΠNM(C)=(32)2×(42)8×(52)6×(72)2×(82)1=1.31×1025 2i
ΠNF(C)=(33)2×(43)8×(53)6×(73)2×(83)1=4.72×1037 2j

The indices for the other drugs can be determined in a similar manner as in eqs – by applying the vertex and edge partition techniques in accordance with their definitions. A comprehensive summary of the computed NDTI values for all drugs is given in Table .

8. Computed NDTI Values for the Candidate H1-Antihistamines.

name NM 1 NF NM 2 NI NH ΠNM 1 ΠNM 2 ΠTN ΠNM ΠNF
diphenhydramine 458 2514 520 49.194 4.214 5.82 × 1019 2.27 × 1027 3.61 × 1012 1.31 × 1025 4.72 × 1037
promethazine 614 3832 748 61.710 4.068 1.06 × 1023 3.82 × 1032 1.17 × 1014 1.37 × 1028 1.60 × 1042
hydroxyzine 682 3920 806 72.248 5.699 1.59 × 1028 2.21 × 1039 3.33 × 1017 1.11 × 1035 3.71 × 1052
pheniramine 442 2450 505 47.250 3.970 7.19 × 1018 1.42 × 1026 9.03 × 1011 8.16 × 1023 7.37 × 1035
cyproheptadine 704 4440 861 70.792 4.574 1.76 × 1026 1.81 × 1037 7.41 × 1015 5.49 × 1031 4.07 × 1047
meclizine 804 4682 938 83.088 5.906 7.62 × 1031 8.14 × 1044 5.63 × 1019 3.17 × 1039 1.78 × 1059
cinnarizine 760 4330 885 80.454 6.144 2.45 × 1031 8.99 × 1043 2.84 × 1019 8.09 × 1038 2.30 × 1058
chlorpheniramine 478 2660 548 50.680 4.075 1.11 × 1020 8.13 × 1027 5.29 × 1012 2.80 × 1025 1.48 × 1038
triprolidine 562 3136 650 59.656 4.522 2.17 × 1023 4.88 × 1032 3.53 × 1014 1.24 × 1029 4.39 × 1043
clemastine 694 4216 825 70.325 4.890 9.02 × 1026 8.26 × 1037 5.23 × 1016 2.73 × 1033 1.43 × 1050
fexofenadine 1114 7022 1322 109.846 7.380 6.67 × 1041 8.41 × 1058 8.56 × 1025 7.33 × 1051 6.28 × 1077
loratadine 840 5274 1023 84.256 5.589 2.40 × 1031 2.54 × 1044 1.05 × 1019 1.10 × 1038 1.16 × 1057
desloaratadine 706 4470 864 70.834 4.593 1.68 × 1026 1.67 × 1037 7.11 × 1015 5.06 × 1031 3.60 × 1047
cetirizine 712 4064 826 74.909 5.803 1.93 × 1029 8.58 × 1040 2.50 × 1018 6.25 × 1036 1.56 × 1055
azelastine 822 4986 988 83.504 5.519 2.27 × 1031 2.50 × 1044 1.60 × 1019 2.56 × 1038 4.10 × 1057
ebastine 974 5550 1130 101.105 7.227 1.20 × 1039 9.55 × 1054 3.28 × 1024 1.07 × 1049 3.52 × 1073
rupatadine 952 5858 1150 96.118 6.170 5.32 × 1035 5.76 × 1050 5.40 × 1021 2.92 × 1043 1.58 × 1065

3. QSPR Analysis of H1-Antihistamines

A quantitative structure–property relationship (QSPR) analysis was conducted on the selected set of H1-antihistamines to investigate the correlation between the molecular structure and key physicochemical properties. The properties considered include boiling point at 760 mmHg (BP in °C), enthalpy of vaporization (EV in kJ/mol), flash point (FP in °C), molar refraction (MR in cm3/mol), polarizability (α in Å3), and molar volume (MV in cm3/mol). The corresponding values were sourced from ChemSpider and are summarized in Table .

9. Physicochemical Properties of the H1-Antihistamines.

sl. no. name BP EV FP MR α MV
1 diphenhydramine 343.7 58.8 101.5 79.6 31.5 249.2
2 promethazine 403.7 65.5 198 87.8 34.8 251.3
3 hydroxyzine 499.2 80.8 255.7 105.9 42 317.1
4 pheniramine 348.3 59.3 164.5 75.9 30.1 236.1
5 cyproheptadine 440.1 69.7 194.5 91.6 36.3 257.5
6 meclizine 495.3 76.3 253.3 118 46.8 337.2
7 cinnarizine 509.2 78 229.8 119.3 47.3 337.2
8 chlorpheniramine 379 62.7 183 80.8 32 248
9 triprolidine 435.4 69.2 217.1 88.1 34.9 262.2
10 clemastine 425.2 68 211 100.4 39.8 313.3
11 fexofenadine 697.3 107.2 375.5 145.9 57.8 428.1
12 loratadine 531.3 80.7 275.1 105.9 42 303.5
13 desloratadine 467.9 73 236.8 90.1 35.7 254.4
14 cetirizine 542.1 86.3 281.6 105.9 42 314.2
15 azelastine 533.9 81 276.7 110 43.6 304.6
16 ebastine 596.3 88.8 314.5 144.7 57.3 428.6
17 rupatadine 586.4 87.6 308.4 122.4 48.5 337.2

To evaluate the predictive accuracy and robustness of the regression models, a set of standard statistical metrics is utilized. These include the coefficient of determination (r 2), root-mean-square error (RMSE), mean absolute error (MAE), standard error (SE), F-statistic, and p-value. In addition to these quantitative measures, graphical validation is carried out through scatter plots to assess the fit between predicted and observed values and residual plots to examine the distribution and patterns of prediction errors.

3.1. Linear Regression Using DTIs

An initial assessment of the strength of association between each physicochemical property and the set of DTIs was conducted by using the correlation coefficient (r). The resulting correlation values are summarized in Table . For each property, the topological index exhibiting the highest correlation is highlighted, thereby indicating promising candidates for subsequent predictive modeling.

10. Correlation Coefficient Values Connecting Physicochemical Properties with DTIs.

  BP EV FP MR α MV
M 1 0.9671 0.9401 0.9250 0.9776 0.9777 0.9370
M 2 0.9644 0.9341 0.9256 0.9578 0.9579 0.9070
H 0.9567 0.9381 0.9015 0.9899 0.9901 0.9646
HM 0.9625 0.9350 0.9263 0.9608 0.9608 0.9175
ABC 0.9639 0.9420 0.9170 0.9897 0.9898 0.9603
R 0.9583 0.9416 0.9061 0.9914 0.9915 0.9700
GA 0.9640 0.9384 0.9132 0.9859 0.9860 0.9479
SCI 0.9617 0.9402 0.9098 0.9899 0.9900 0.9598
IS 0.9670 0.9369 0.9214 0.9743 0.9744 0.9264
SD 0.9563 0.9400 0.9174 0.9835 0.9835 0.9667
F 0.9588 0.9338 0.9249 0.9614 0.9613 0.9247
ABS 0.9661 0.9402 0.9200 0.9850 0.9851 0.9475

To evaluate the predictive capability of the TIs, linear regression analysis was conducted for each physicochemical property using the index that exhibited the highest correlation. The employed regression model follows the form y = z 0 + z 1 X, where y represents the physicochemical property, z 0 is the intercept, and z 1 is the regression coefficient corresponding to topological index X. A comprehensive statistical summary of the regression parameters for the most strongly correlated DTIs is presented in Table .

11. Regression Analysis of the Physicochemical Properties Related to DTIs.

  BP–M 1 EV–ABC FP–HM MR–R α–R MV–R
r 2 0.9353 0.8873 0.8580 0.9829 0.9831 0.9408
adjusted r 2 0.9310 0.8798 0.8485 0.9817 0.9820 0.9369
RMSE 23.1821 4.0491 23.6185 2.6598 1.0471 13.7707
MAE 19.0942 3.0775 18.9219 2.1025 0.8327 11.3949
SE 24.6792 4.3106 25.1438 2.8316 1.1148 14.6601
F-statistic 216.9 118.1 90.61 861.2 872.5 238.5
p-value 2.51 × 10–10 1.66 × 10–8 9.52 × 10–8 1.15 × 10–14 1.05 × 10–14 1.29 × 10–10
z 0 95.8348 23.3720 1.5424 6.6682 2.6475 38.7986
z 1 2.9753 2.6741 0.3777 7.9182 3.1377 21.5746

Accordingly, the best-fitting regression equations for each physicochemical property are summarized in eqs –, with the corresponding regression curves illustrated in Figure , and the associated residual plots are shown in Figure , collectively demonstrating the quality of fit achieved by the selected topological descriptors.

(BP)=2.9753(M1)+95.835 3a
(EV)=2.6741(ABC)+23.372 3b
(FP)=0.3777(HM)+1.5424 3c
(MR)=7.9182(R)+6.6682 3d
(α)=3.1377(R)+2.6475 3e
(MV)=21.575(R)+38.799 3f

2.

2

Best-fit regression curves for the physicochemical properties with respect to DTIs.

3.

3

Residual plots for best-fit models with respect to DTIs.

3.2. Linear Regression Using Additive NDTIs

Similar to the approach used for DTIs, a preliminary analysis was conducted using correlation coefficients to examine the relationship between physicochemical properties and additive NDTIs. The resulting values are presented in Table .

12. Correlation Coefficient Values Connecting Physicochemical Properties with additive NDTIs.

  BP EV FP MR α MV
NM 1 0.9561 0.9233 0.9215 0.9358 0.9360 0.8775
NF 0.9271 0.8950 0.8983 0.8751 0.8753 0.8067
NM 2 0.9431 0.9077 0.9125 0.9059 0.9061 0.8383
NI 0.9638 0.9306 0.9249 0.9584 0.9585 0.9039
NH 0.9375 0.9264 0.8778 0.9833 0.9834 0.9708

Based on the highest correlations, linear regression analysis was performed (see Table ), followed by the formulation of the corresponding regression equations (see eqs –).

13. Regression Analysis of the Physicochemical Properties Related to Additive NDTIs.

  BP–NI EV–NI FP–NI MR–NH α–NH MV–NH
r 2 0.9288 0.8661 0.8554 0.9668 0.9672 0.9425
adjusted r 2 0.9241 0.8571 0.8457 0.9646 0.9650 0.9387
RMSE 24.3200 4.4138 23.8319 3.7020 1.4596 13.5694
MAE 19.3256 3.5384 19.4738 2.9461 1.1612 11.2860
SE 25.8906 4.6989 25.3710 3.9411 1.5539 14.4458
F-statistic 195.7 97 88.73 437.3 441.8 246.1
p-value 5.17 × 10–10 6.10 × 10–8 1.09 × 10–7 1.65 × 10–12 1.53 × 10–12 1.03 × 10–10
z 0 106.4276 27.7669 –9.5230 1.5493 0.6167 22.2812
z 1 5.0752 0.6484 3.3483 19.3262 7.6589 53.1417

The regression curves corresponding to the best-fitting regression equations are shown in Figure , and the residual plots are shown in Figure , illustrating the quality of fit achieved by the selected topological descriptors.

(BP)=5.0752(NI)+106.4276 4a
(EV)=0.6484(NI)+27.7669 4b
(FP)=3.3483(NI)9.5230 4c
(MR)=19.3262(NH)+1.5493 4d
(α)=7.6589(NH)+0.6167 4e
(MV)=53.1417(NH)+22.2812 4f

4.

4

Best-fit regression curves for the physicochemical properties with respect to additive NDTIs.

5.

5

Residual plots for best-fit models with respect to additive NDTIs.

3.3. Logarithmic Regression Using Multiplicative NDTIs

In the case of multiplicative NDTIs, it is observed that their natural logarithms exhibit stronger agreement with the physicochemical properties compared to the original values. Additionally, the raw index values are considerably large, making their logarithmic forms more manageable for analysis and visualization. The corresponding natural logarithmic values are listed in Table , and their correlations with the physicochemical properties are presented in Table .

14. Natural Logarithm Values for the Multiplicative NDTIs.

name ln(ΠNM 1) ln(ΠNM 2) ln(ΠTN) ln(ΠNM) ln(ΠNF)
diphenhydramine 45.51 62.99 28.92 57.83 86.75
promethazine 53.02 75.02 32.39 64.79 97.18
hydroxyzine 64.93 90.59 40.35 80.70 121.04
pheniramine 43.42 60.22 27.53 55.06 82.59
cyproheptadine 60.43 85.79 36.54 73.08 109.62
meclizine 73.41 103.41 45.48 90.95 136.43
cinnarizine 72.27 101.21 44.79 89.59 134.38
chlorpheniramine 46.16 64.27 29.30 58.59 87.89
triprolidine 53.73 75.27 33.50 66.99 100.49
clemastine 62.07 87.31 38.49 76.99 115.48
fexofenadine 96.30 135.68 59.71 119.42 179.14
loratadine 72.26 102.25 43.80 87.60 131.39
desloaratadine 60.39 85.71 36.50 73.00 109.50
cetirizine 67.43 94.25 42.36 84.73 127.09
azelastine 72.20 102.23 44.22 88.44 132.66
ebastine 89.99 126.60 56.45 112.90 169.35
rupatadine 82.26 116.88 50.04 100.08 150.12

15. Correlation Coefficient Values Connecting Physicochemical Properties with Natural Logarithm of the Multiplicative NDTIs.

  BP EV FP MR α MV
ln(ΠNM 1) 0.9672 0.9394 0.9232 0.9789 0.9790 0.9369
ln(ΠNM 2) 0.9664 0.9365 0.9239 0.9742 0.9743 0.9284
ln(ΠTN) 0.9643 0.9405 0.9188 0.9879 0.9879 0.9557
ln(ΠNM) 0.9643 0.9405 0.9188 0.9879 0.9879 0.9557
ln(ΠNF) 0.9643 0.9405 0.9188 0.9879 0.9879 0.9557

Based on the most strongly correlated pairs, logarithmic regression analysis was performed using the model y = z 0 + z 1 ln­(X), where y represents the physicochemical property, z 0 is the intercept, and z 1 is the regression coefficient associated with the natural logarithm of the multiplicative NDTI­(X). The results of this analysis are summarized in Table , and the corresponding regression equations are presented in eqs –.

(BP)=6.0161ln(ΠNM1)+89.5110 5a
(EV)=1.2664ln(ΠTN)+24.6252 5b
(FP)=2.7673ln(ΠNM2)15.6917 5c
(MR)=2.2420ln(ΠTN)+13.2073 5d
(α)=0.8884ln(ΠTN)+5.2408 5e
(MV)=6.0403ln(ΠTN)+59.3899 5f

16. Regression Analysis of the Physicochemical Properties Related to Multiplicative NDTIs.

  BP–ln(ΠNM 1) EV–ln(ΠTN) FP–ln(ΠNM 2) MR–ln(ΠTN) α–ln(ΠTN) MV–ln(ΠTN)
r 2 0.9354 0.8845 0.8537 0.9759 0.9760 0.9134
adjusted r 2 0.9311 0.8768 0.8439 0.9743 0.9744 0.9076
RMSE 23.1651 4.0987 23.9735 3.1572 1.2482 16.6644
MAE 19.1819 3.0967 20.1366 2.7030 1.0705 14.0778
SE 24.6611 4.3634 25.5218 3.3611 1.3288 17.7406
F-statistic 217.3 114.9 87.5 606.8 609.6 158.1
p-value 2.48 × 10–10 1.99 × 10–8 1.19 × 10–7 1.51 × 10–13 1.46 × 10–13 2.28 × 10–9
z 0 89.5110 24.6252 –15.6917 13.2073 5.2408 59.3899
z 1 6.0161 1.2664 2.7673 2.2420 0.8884 6.0403

The scatter plots corresponding to the best-fitting models, based on the natural logarithm of the respective multiplicative NDTIs, along with the associated residual plots, are presented in Figures and , respectively.

6.

6

Best-fit regression curves for the physicochemical properties with respect to multiplicative NDTIs.

7.

7

Residual plots for best-fit models with respect to multiplicative NDTIs.

3.4. Prediction of Physicochemical Properties

To assess the generalizability of the developed models, two additional H1-antihistaminescyclizine and doxylaminewere analyzed. Their molecular structures are shown in Figure , and the corresponding TIs, computed, as described in Theorems 1 and 2, are listed in Table . Using the previously established regression models (eqs –, –, and –), predictions for their physicochemical properties were generated and compared with the actual values. The results are illustrated in Figure , along with a comparison table where the predicted values from model 1 (eqs –), model 2 (eqs –), and model 3 (eqs –) are displayed.

8.

8

Chemical structures of additional antihistamines.

17. Selected TIs for Cyclizine and Doxylamine.

  M 1 ABC HM R NI NH ln(ΠNM 1) ln(ΠNM 2) ln(ΠTN)
cyclizine 102 15.5444 484 9.8433 58.076 4.314 51.62 72.42 31.94
doxylamine 98 15.1037 476 9.6268 54.309 4.243 48.89 68.09 30.87

9.

9

Comparison between predicted and actual values of the physicochemical properties for cyclizine and doxylamine with respect to the derived regression models, namely model 1 (eqs –), model 2 (eqs –), and model 3 (eqs –).

4. Discussion

All of the derived models demonstrated high r 2 values, almost every value exceeding 0.90, indicating that the selected TIs explain a substantial proportion of the variability in the physicochemical properties. The adjusted r 2, which corrects for the number of predictors, remained closely aligned with the unadjusted r 2, confirming that the models are not overfitted and that the descriptors are relevant contributors.

Error-based metrics, such as RMSE and MAE, were consistently low, highlighting the minimal average deviation between predicted and observed values. RMSE reflects the standard deviation of prediction errors, while MAE captures the average absolute difference, both confirming the high predictive accuracy of the models. Similarly, the SE values remained low across the models, suggesting a strong fit of the data to the regression line.

The F-statistic values, which assess the overall significance of the regression, were notably high with corresponding p-values far below the conventional significance level of 0.05. This confirms that the models are statistically significant and that the TIs play a meaningful role in predicting the molecular properties.

In addition to numerical measures, graphical tools were employed to visually validate the models. Scatter plots confirmed the linearity and strength of the associations, with data points closely clustered around the ideal fit line. Residual plots were also examined to assess the distribution of the prediction errors. The absence of discernible patterns or systematic deviations in these plots suggests that model assumptions, such as homoscedasticity and linearity, are reasonably satisfied.

Among the physicochemical properties examined, the models defined in eqs –, –, and – provide the best predictions for polarizability (α), MR, MV, and BP, as indicated by their high r 2 values, averaging 0.975, 0.975, 0.932, and 0.933, respectively. EV and FP exhibit moderate but acceptable correlations, with mean r 2 values of 0.879 and 0.856.

Among all TIs considered, the Randi index consistently exhibits strong predictive power across multiple DTIs, particularly for MR, α, and MV, where it achieves near-unity correlation coefficients (refer Table ). This highlights the Randić index as a reliable and effective structural descriptor. In the class of additive NDTIs, the NI and NH indices demonstrate superior predictive capabilities (refer Table ). These findings underline the fact that reverse degree indices perform exceptionally well among the evaluated descriptors, as they not only exhibit stronger statistical correlations with physicochemical properties but also capture subtle structural variations more effectively than conventional indices. For the multiplicative NDTIs, all the considered indices, in particular ΠTN, ΠNM, and ΠNF, emerge as effective predictors for specific properties (refer Table ). The multiplicative NDTIs outperformed the additive NDTIs in all cases except for the prediction of the MV. Although DTIs generally showed superior performance in the analysis, their advantage over the multiplicative NDTIs was marginal, indicating that the two sets of descriptors exhibit nearly equivalent predictive capability. The ability of NDTIs to highlight secondary structural effects makes them valuable for enriching QSPR models, as they contribute new insights into the relationship between molecular topology and chemical behavior, even when their standalone predictive strength appears weaker.

To assess the external validity of the derived models, two additional H1-antihistamines, namely, cyclizine and doxylamine, were analyzed. As shown in Figure , the predicted values align closely with the experimentally observed data, especially for MR, α, and MV. Although minor deviations are noted for other properties, the overall predictions remain within an acceptable margin, indicating that the models possess good generalizability.

Beyond statistical observations, meaningful chemical inferences can also be drawn from the data set. For instance, cyclizine is a tricyclic compound with relatively less branching, while doxylamine is a bicyclic compound exhibiting greater branching (Figure ). This structural difference is reflected in the predictive performance of the models (Figure ): properties such as BP, EV, and FP are more accurately predicted for doxylamine, whereas MR shows better agreement with actual values in the case of cyclizine. Interestingly, both compounds exhibit close predictive-experimental correspondence for parameters like MR and polarizability. These findings suggest that the number of cycles in the molecular framework and the extent of branching play a significant role in determining how well certain physicochemical properties can be modeled, offering valuable insights into the interplay between structure and property prediction in QSPR analysis.

These results affirm the utility of TIs in modeling structure–property relationships. By leveraging topological descriptors within the QSPR paradigm, researchers can efficiently screen and optimize drug candidates in the early stages of development, significantly reducing the need for extensive experimental trials.

5. Conclusions

In this study, a QSPR-based approach utilizing DTIs and NDTIs was employed to model and predict key physicochemical properties of H1-antihistamines. Overall, the combination of strong statistical indicators and supportive graphical validation demonstrates that the developed models are both accurate and generalizable, making TIs effective descriptors in the QSPR analysis of the selected drug compounds. For NDTIs, although the observed correlation coefficients with physicochemical properties were relatively lower compared to conventional degree-based indices, they provide complementary values by offering additional structural sensitivity. Validation using external compounds, cyclizine and doxylamine, confirmed the generalizability of the model. Also, the analysis highlights that the number of cycles and the degree of branching in molecular structures critically influence the accuracy of the QSPR property predictions. Overall, this study demonstrates that computational analysis using topological descriptors not only reduces experimental effort but also offers superior insights into the molecular factors influencing drug behavior, thereby supporting the rational design of next-generation antihistamines.

This work can be extended by exploring other types of indices, such as domination-based TIs, and by modeling additional physicochemical or pharmacokinetic properties. Such analyses can be conducted not only on the same class of drugs but also across other classes of drugs or chemical compounds, thereby broadening the applicability and scope of the QSPR framework.

Acknowledgments

The authors gratefully acknowledge financial support from Vellore Institute of Technology, Vellore, Tamilnadu, India.

All chemical structures used in this study were retrieved from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/). The corresponding physicochemical properties were obtained from the ChemSpider database (https://www.chemspider.com/). Statistical analyses and graphical representations were performed using Python and Microsoft Excel. All relevant data are provided within the manuscript.

The authors declare no competing financial interest.

References

  1. Tripathi, K. Essentials of Medical Pharmacology, 8th ed.; Jaypee Brothers Medical Publishers: New Delhi, India, 2018. [Google Scholar]
  2. Monczor F., Fernandez N.. Current knowledge and perspectives on histamine H1 and H2 receptor pharmacology: functional selectivity, receptor crosstalk, and repositioning of classic histaminergic ligands. Mol. Pharmacol. 2016;90(5):640–648. doi: 10.1124/mol.116.105981. [DOI] [PubMed] [Google Scholar]
  3. Schaefer, T. S. ; Patel, P. ; Zito, P. M. . Antiemetic histamine H1 receptor blockers. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK533003/. [PubMed] [Google Scholar]
  4. Farzam, K. ; Sabir, S. ; O’Rourke, M. C. . Antihistamines. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538188/. [PubMed] [Google Scholar]
  5. Pirahanchi, Y. ; Sharma, S. . Physiology, bradykinin. In StatPearls [Internet]; StatPearls Publishing, 2023. [PubMed] [Google Scholar]
  6. Fritz I., Wagner P., Broberg P., Einefors R., Olsson H.. Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival. Acta Oncol. 2020;59(9):1103–1109. doi: 10.1080/0284186X.2020.1769185. [DOI] [PubMed] [Google Scholar]
  7. Fritz I., Wagner P., Bottai M., Eriksson H., Ingvar C., Krakowski I., Nielsen K., Olsson H.. Desloratadine and loratadine use associated with improved melanoma survival. Allergy. 2020;75(8):2096–2099. doi: 10.1111/all.14273. [DOI] [PubMed] [Google Scholar]
  8. Fritz I., Wagner P., Olsson H.. Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine. Transl. Oncol. 2021;14(4):101029. doi: 10.1016/j.tranon.2021.101029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hsieh C.-Y., Tsai T.-F.. Use of H-1 antihistamine in dermatology: more than itch and urticaria control: a systematic review. Dermatol. Ther. 2021;11(3):719–732. doi: 10.1007/s13555-021-00524-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Shanmukha M., Basavarajappa N., Shilpa K., Usha A.. Degree-based topological indices on anticancer drugs with QSPR analysis. Heliyon. 2020;6(6):e04235. doi: 10.1016/j.heliyon.2020.e04235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mahboob A., Rasheed M. W., Dhiaa A. M., Hanif I., Amin L.. On quantitative structure-property relationship (QSPR) analysis of physicochemical properties and anti-hepatitis prescription drugs using a linear regression model. Heliyon. 2024;10(4):e25908. doi: 10.1016/j.heliyon.2024.e25908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Awan N. u. H., Ghaffar A., Tawfiq F. M., Mustafa G., Bilal M., Inc M.. QSPR analysis for physiochemical properties of new potential antimalarial compounds involving topological indices. Int. J. Quantum Chem. 2024;124(11):27391. doi: 10.1002/qua.27391. [DOI] [Google Scholar]
  13. Bokhary S. A. U. H., Adnan, Siddiqui M. K., Cancan M.. On topological indices and QSPR analysis of drugs used for the treatment of breast cancer. Polycyclic Aromat. Compd. 2022;42(9):6233–6253. doi: 10.1080/10406638.2021.1977353. [DOI] [Google Scholar]
  14. Hasani M., Ghods M., Mondal S., Siddiqui M. K., Cheema I. Z.. Modeling QSPR for pyelonephritis drugs: a topological indices approach using MATLAB. J. Supercomput. 2025;81(3):479. doi: 10.1007/s11227-025-06967-8. [DOI] [Google Scholar]
  15. Huang R., Mahboob A., Rasheed M. W., Alam S. M., Siddiqui M. K.. On molecular modeling and QSPR analysis of lyme disease medicines via topological indices. Eur. Phys. J. Plus. 2023;138(3):243. doi: 10.1140/epjp/s13360-023-03867-9. [DOI] [Google Scholar]
  16. Huang L., Alhulwah K. H., Hanif M. F., Siddiqui M. K., Ikram A. S.. On QSPR analysis of glaucoma drugs using machine learning with XGBoost and regression models. Comput. Biol. Med. 2025;187:109731. doi: 10.1016/j.compbiomed.2025.109731. [DOI] [PubMed] [Google Scholar]
  17. B G. K., Roy S.. Quantitative structure property relationship study of postpartum depression medications using topological indices and regression models. Ain Shams Eng. J. 2025;16(1):103194. doi: 10.1016/j.asej.2024.103194. [DOI] [Google Scholar]
  18. Al-Dayel I., Khan M. A., Hanif M. F., Siddiqui M. K., Hanif S., Gegbe B.. A graph-based computational approach for modeling physicochemical properties in drug design. Sci. Rep. 2025;15(1):21170. doi: 10.1038/s41598-025-06624-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Balasubramaniyan D., Chidambaram N.. On some neighbourhood degree-based topological indices with QSPR analysis of asthma drugs. Eur. Phys. J. Plus. 2023;138(9):823. doi: 10.1140/epjp/s13360-023-04439-7. [DOI] [Google Scholar]
  20. Pegu A., Borah S., Bharali A.. Predictive ability of some neighborhood degree-based topological indices for antituberculosis drugs. Indian J. Sci. Technol. 2023;16(26):1986–1996. doi: 10.17485/IJST/v16i26.615. [DOI] [Google Scholar]
  21. Thamizhmaran R., Kalaimurugan G., Siddiqui M. K., Vinnarasi L., Yuvaraj A., Hanif M. F.. Utilizing neighborhood topological indices for QSPR analysis of clinically approved immunosuppressive drugs in heart transplant therapy. Comput. Biol. Chem. 2025;117:108414. doi: 10.1016/j.compbiolchem.2025.108414. [DOI] [PubMed] [Google Scholar]
  22. Manuel M., A. P.. A graph-theoretical approach to characterizing anaesthetic agents using topological indices and QSPR models. Comput. Biol. Chem. 2025;119:108544. doi: 10.1016/j.compbiolchem.2025.108544. [DOI] [PubMed] [Google Scholar]
  23. National Center for Biotechnology Information . PubChem Database. https://pubchem.ncbi.nlm.nih.gov/ (Accessed date 23 May 2025).
  24. West, D. B. ; et al. Introduction to Graph Theory; Prentice Hall: Upper Saddle River, 2001; Vol. 2. [Google Scholar]
  25. Trinajstic, N. Chemical Graph Theory; CRC Press: Boca Raton, 2018. [Google Scholar]
  26. Estrada E., Torres L., Rodriguez L., Gutman I.. An atom-bond connectivity index: modelling the enthalpy of formation of alkanes. Indian J. Chem., Sect. A. 1998;37:849–855. [Google Scholar]
  27. Ali A., Furtula B., Redžepović I., Gutman I.. Atom-bond sum-connectivity index. J. Math. Chem. 2022;60(10):2081–2093. doi: 10.1007/s10910-022-01403-1. [DOI] [Google Scholar]
  28. Furtula B., Gutman I., Dehmer M.. On structure-sensitivity of degree-based topological indices. Appl. Math. Comput. 2013;219(17):8973–8978. doi: 10.1016/j.amc.2013.03.072. [DOI] [Google Scholar]
  29. Vukičević D., Furtula B.. Topological index based on the ratios of geometrical and arithmetical means of end-vertex degrees of edges. J. Math. Chem. 2009;46:1369–1376. doi: 10.1007/s10910-009-9520-x. [DOI] [Google Scholar]
  30. Fajtlowicz S.. On conjectures of graffiti. Ann. Discrete Math. 1988;72:113–118. doi: 10.1016/0012-365x(88)90199-9. [DOI] [Google Scholar]
  31. Vukičević D., Gašperov M.. Bond additive modeling 1. Adriatic indices. Croat. Chem. Acta. 2010;83(3):243–260. [Google Scholar]
  32. Randic M.. Characterization of molecular branching. J. Am. Chem. Soc. 1975;97(23):6609–6615. doi: 10.1021/ja00856a001. [DOI] [Google Scholar]
  33. Zhou B., Trinajstić N.. On general sum-connectivity index. J. Math. Chem. 2010;47:210–218. doi: 10.1007/s10910-009-9542-4. [DOI] [Google Scholar]
  34. Vasilyev A.. Upper and lower bounds of symmetric division deg index. Iran. J. Math. Chem. 2014;5:91–98. doi: 10.22052/ijmc.2014.7357. [DOI] [Google Scholar]
  35. Gutman I., Trinajstić N.. Graph theory and molecular orbitals. Total φ-electron energy of alternant hydrocarbons. Chem. Phys. Lett. 1972;17(4):535–538. doi: 10.1016/0009-2614(72)85099-1. [DOI] [Google Scholar]
  36. Shirdel G. H., Rezapour H., Sayadi A.. The hyper-Zagreb index of graph operations. Iran. J. Math. Chem. 2013;4:213–220. doi: 10.22052/ijmc.2013.5294. [DOI] [Google Scholar]
  37. Mondal S., De N., Pal A.. On neighborhood Zagreb index of product graphs. J. Mol. Struct. 2021;1223:129210. doi: 10.1016/j.molstruc.2020.129210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mondal S., De N., Pal A.. On some new neighborhood degree-based indices for some oxide and silicate networks. J. 2019;2(3):384–409. doi: 10.3390/j2030026. [DOI] [Google Scholar]
  39. Mondal S., Siddiqui M. K., De N., Pal A.. Neighborhood M-polynomial of crystallographic structures. Biointerface Res. Appl. Chem. 2021;11(2):9372–9381. doi: 10.33263/BRIAC112.93729381. [DOI] [Google Scholar]
  40. Mondal S., De N., Pal A.. On some general neighborhood degree based topological indices. Int. J. Appl. Math. 2019;32(6):1037–1049. doi: 10.12732/ijam.v32i6.10. [DOI] [Google Scholar]
  41. Royal Society of Chemistry . ChemSpider: Search and Share Chemistry. https://www.chemspider.com/ (Accessed date 23 May 2025).

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All chemical structures used in this study were retrieved from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/). The corresponding physicochemical properties were obtained from the ChemSpider database (https://www.chemspider.com/). Statistical analyses and graphical representations were performed using Python and Microsoft Excel. All relevant data are provided within the manuscript.


Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES